Genetics Generation Advancement Balance Sheet Health
Financial Health criteria checks 5/6
Genetics Generation Advancement has a total shareholder equity of NT$575.1M and total debt of NT$30.0M, which brings its debt-to-equity ratio to 5.2%. Its total assets and total liabilities are NT$759.5M and NT$184.4M respectively. Genetics Generation Advancement's EBIT is NT$55.9M making its interest coverage ratio -12.4. It has cash and short-term investments of NT$425.9M.
Key information
5.2%
Debt to equity ratio
NT$30.00m
Debt
| Interest coverage ratio | -12.4x |
| Cash | NT$425.92m |
| Equity | NT$575.12m |
| Total liabilities | NT$184.41m |
| Total assets | NT$759.54m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4160's short term assets (NT$591.7M) exceed its short term liabilities (NT$180.0M).
Long Term Liabilities: 4160's short term assets (NT$591.7M) exceed its long term liabilities (NT$4.4M).
Debt to Equity History and Analysis
Debt Level: 4160 has more cash than its total debt.
Reducing Debt: 4160's debt to equity ratio has increased from 0% to 5.2% over the past 5 years.
Debt Coverage: 4160's debt is well covered by operating cash flow (330.2%).
Interest Coverage: 4160 earns more interest than it pays, so coverage of interest payments is not a concern.